Skip to content
Advertisement

Doses of the COVID-19 vaccine developed by Oxford University and U.K.-based drugmaker AstraZeneca are logged by a technical officer, as they arrive at the Princess Royal Hospital in Haywards Heath, England, Saturday, Jan. 2, 2021. The U,K, has 530,000 doses available for rollout from Monday. (Gareth Fuller/Pool via AP)

Doses of the COVID-19 vaccine developed by Oxford University and U.K.-based drugmaker AstraZeneca are logged by a technical officer, as they arrive at the Princess Royal Hospital in Haywards Heath, England, Saturday, Jan. 2, 2021. The U,K, has 530,000 doses available for rollout from Monday. (Gareth Fuller/Pool via AP)

Featured Photo Galleries